http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-768813-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b6fc801b5bfe5304ffa40d938db6e09
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1955-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1957-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-768813-A
titleOfInvention Substituted 1.2-diphenyl-3.5-dioxo-pyrazolidines and processes for the production thereof
abstract The invention comprises compounds of the general formula <FORM:0768813/IV(b)/1> wherein Ar1 and Ar2 are phenyl radicals which may be substituted by alkyl, alkoxy or alkyl mercapto groups of 1 to 4 carbon atoms or by halogen, R1 and R2 are hydrogen or methyl and n is 0-3, their salts with inorganic or organic bases, and their preparation by (a) condensing, preferably in the presence of an alkaline condensation agent, a diester of the appropriately mono-substituted malonic acid with the appropriate 1,2-diarylhydrazine or an N-acyl derivative thereof or (b) condensing in the presence of an acid binding agent, a dichloride, dibromide or mixed anhydride of the appropriately monosubstituted malonic acid with the appropriate 1 : 2-diarylhydrazine or (c) condensing an appropriately mono-substituted malonic acid mono-ester mono-chloride, bromide or mixed anhydride first, corresponding to (b), with the appropriate diarylhydrazine to form a substituted malonic acid hydrazide ester and then condensing, corresponding to (a), to form the required product, and, if desired, converting the products so obtained into their salts with inorganic or organic bases. Alkaline condensation agents referred to are alkali metals, their alcoholates, amides, hydroxides and hydrides, the condensation preferably being performed in an organic solvent at a raised temperature. Acid binding agents referred to are tertiary organic bases, the condensation being effected with or without organic solvents at temperatures near 0 DEG C., with subsequent heating if desired. Salts according to the invention are prepared by reacting the free pyrazolidinediones in aqueous solution or an organic solvent with an inorganic or organic base, e.g. sodium or potassium hydroxide or carbonate, sodium alcoholate or mono-, di- or tri-ethanolamine or ethylene diamine. Examples describe the preparation of the following 3.5-dioxo-pyrazolidines: 1 : 2 - diphenyl - 4 - (21 : 51 - endomethylene - D 31 - cyclohexenyl - methyl)-, 1 : 2 - di - phenyl - 4 - (21 : 51 - endomethylene - D 31-cyclo-hexenyl)-, 1 : 2 - diphenyl - 4 - (61 - methyl - 21 : 51-endomethylene - D 31 - cyclohexenyl - methyl)-, 1 : 2 - diphenyl - 4 [31 - (211 : 511 - endomethyleneD 311-cyclohexenyl) - propyl - (11)]-, 1 : 2 - di - (p - methyl - phenyl) - 4 - (21 : 51 - endomethylene - D 31 - cyclohexenyl)-, 1 : 2 - di - (p - chlor - phenyl) - 4 - 21 : 51 - endomethylene - D 31 - cyclohexenyl)-, 1 : 2-di-(m-brom-phenyl)-4-(21 : 51-endomethylene - D 31 - cyclohexenyl)-, 1 : 2 - di - (m-methylmercapto) - 4 - [21 : 51 - endomethylene - D 31-cyclohexenyl - (11)]- and 1 : 2 - di - (p - methoxy-phenyl) - 4 - [21 : 51 - endomethylene-D 31-cyclohexenyl - (11)]-; a - (2 : 5 - endomethylene - D 3-cyclohexenyl) - a - carbethoxyacetylhydrazo - benzene is an intermediate in one preparation of the second of the above compounds. The preparation of sodium salts of some of the above compounds is also described. A list of further starting materials is also given, including 4-ethoxy-41-bromo-hydrazobenzene. Starting materials. Compounds of the general formula <FORM:0768813/IV(b)/2> where X is a hydrocarbon radical, are prepared by condensation of sodium malonic acid diesters with the appropriate 21 : 51-endomethylene-D 31-cyclohexenyl-alkyl halides, themselves prepared by the addition of cyclopentadiene to unsaturated aliphatic halogen compounds such as vinyl bromide, allyl chloride or methallyl chloride. Acid halides are obtained from the above esters by alkaline saponification, liberation of the acids and treatment thereof with inorganic acid halides. Mixed anhydrides, when X is an acetyl radical, are obtained from the free acid and excess acetic anhydride. In the examples, the following compounds are prepared by the above methods: malonic acid diethyl esters, free acids and dichlorides substituted by [(6-methyl-2 : 5-endomethylene-D 3-cyclohexenyl - methyl)]- and [2 : 5 - endomethylene - D 3 - cyclohexenyl - (1)] - radicals, [3-(21 : 51 - endomethylene - D 31 - cyclohexenyl)-propyl-(1)]-malonic acid diethyl ester and 6-methyl - 2 : 5 - endomethylene - D 3 - cyclo - hexenyl - methyl bromide. 1-Bromobutene-(2) is prepared from butadiene and hydrogen bromide in glacial acetic acid. 3-(21 : 51-Endomethylene - D 3 - cyclohexenyl) - propyl bromide is obtained from PBr3 and the corresponding propanol, itself obtained by converting 2 : 5-endomethylene - D 3 - cyclohexenyl - (1) - methyl bromide into the corresponding Grignard compound and reacting this with ethylene oxide. p.p1 - Dimethyl-, p.p1-dichloro-, m.m1-dibromo- and m.m1 - dimethylmercapto - hydrazo - benzenes are produced by reduction with zinc dust and alkali of p-nitrotoluene, p-nitrochlorobenzene, m-bromonitrobenzene and mi-nitrothioanisole respectively. Specification 646,597 is referred to.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6391518-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6369181-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6987155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2336843-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2336843-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6265130-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6586619-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6569971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291131-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6410670-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6608158-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6376632-B1
priorityDate 1954-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21863620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416013216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53445323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449662972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414868138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412016948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421789662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415113610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID565473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454716784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557696

Total number of triples: 84.